It is relatively well established that diabetes also increases overall cardiac O-GlcNAc levels [14], [20]; it is possible, therefore, that in the diabetic heart O-GlcNAcylation of FAT/CD36 may shift the balance towards sarcolemmal localization of FAT/CD36 possibly by inhibiting recycling. This evidence concerns the gene CD36 and diabetes mellitus.